| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/30/1991 | EP0410147A1 Modified VP1/P2A regions of rhinovirus systems |
| 01/30/1991 | EP0410006A1 Eye drops for healing wound of corneal epithelium |
| 01/30/1991 | EP0409962A1 Agent for inhibiting symmetrical proteins, in particular enzymes. |
| 01/30/1991 | EP0409940A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids. |
| 01/30/1991 | EP0409901A1 Lak cell cytotoxin |
| 01/30/1991 | CA2051124A1 Proteins with tnf activity |
| 01/30/1991 | CA2022055A1 Dental plaque-degrading compositions |
| 01/29/1991 | WO1991001997A1 Treatment to reduce edema for brain and musculature injuries |
| 01/29/1991 | WO1991001738A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | US4988676 Suppression of antigens, mitogens or alloantigens in blood as antitumor agents |
| 01/29/1991 | US4988675 Applying insulin-like growth factor I inemia in diabetics |
| 01/29/1991 | US4988622 Recombinant plasmid DNA pVN 22 coding biosynthesis of human leukocyte interferon alpha-I1 and strain Pseudomonas sp. 31 (pVN 22) - producer of human leukocyte interferon alpha-I1 containing same |
| 01/29/1991 | US4988512 Nasal pharmaceutical compositions |
| 01/29/1991 | CA2064036A1 Dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility |
| 01/29/1991 | CA2021953A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021952A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021951A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021950A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021949A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021948A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021944A1 Antiherpetic agents |
| 01/29/1991 | CA1279591C High level production of bovine growth hormone |
| 01/29/1991 | CA1279572C Composition and method for osseous repair |
| 01/28/1991 | CA2022146A1 Immunosuppressive monoclonal antibodies, hybridomas and methods of transplantation |
| 01/27/1991 | WO1991001990A1 Chimeric anti-cea antibody |
| 01/27/1991 | CA2021740A1 Peptidyl aminodiol renin inhibitors |
| 01/27/1991 | CA2021660A1 Peptidase inhibitors |
| 01/26/1991 | WO1991001329A1 Polypeptide inhibitor of viral replication |
| 01/26/1991 | WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 01/26/1991 | CA2063801A1 Polypeptide inhibitor of viral replication |
| 01/26/1991 | CA2021822A1 Renin-inhibiting amino oligohydroxy derivatives |
| 01/26/1991 | CA2021739A1 Immunostimulating proteins, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas for uses in therapy and diagnosis |
| 01/25/1991 | CA2021452A1 Stabilization of highly purified proteins |
| 01/24/1991 | WO1991000919A1 Promoters of colony stimulating factor activity |
| 01/24/1991 | WO1991000916A2 Receptors for fibroblast growth factors |
| 01/24/1991 | WO1991000907A1 Monocyte chemotactic proteins and related peptides |
| 01/24/1991 | WO1991000904A1 Expression of retrovirus gag protein in eukaryotic cells |
| 01/24/1991 | WO1991000871A1 Surfactant compositions and methods |
| 01/24/1991 | WO1991000869A1 Substitution analogues of magainin peptides |
| 01/24/1991 | WO1991000737A1 Treatment of obesity and essential hypertension and related disorders |
| 01/24/1991 | WO1991000710A1 Treatment of bone disorders |
| 01/24/1991 | DE3917949A1 New fibrin specific thrombolytic agent v-PA |
| 01/24/1991 | CA2035861A1 Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0409607A2 Antibody to human interleukin-6 receptor |
| 01/23/1991 | EP0409472A1 Bone morphogenetic protein |
| 01/23/1991 | EP0409242A1 Monoclonal antibody against human CD4 peptide |
| 01/23/1991 | EP0409148A2 Improving cheese production |
| 01/23/1991 | EP0409113A1 Human erythropoietin muteins, their production and their use |
| 01/23/1991 | EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus |
| 01/23/1991 | EP0409052A2 Anticoagulant containing agent |
| 01/23/1991 | EP0409045A2 Pentapeptide antibiotics derived from dalbaheptides |
| 01/23/1991 | EP0409040A1 Antibodies to Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0408973A1 Antiherpes pentapeptides |
| 01/23/1991 | EP0408933A2 A mutant of pseudomonas, a strain yzh, and a process for producing 851yzh nutrient solution by application of the strain |
| 01/23/1991 | EP0408859A2 Monoclonal antibodies to activated endothelial cells |
| 01/23/1991 | EP0408663A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
| 01/23/1991 | EP0408649A1 Bone and cartilage inductive compositions |
| 01/23/1991 | EP0189481B1 Insulin-like growth factor ii |
| 01/22/1991 | WO1991002002A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 01/22/1991 | US4987237 Immunostimulant suitable for coupling to other materials |
| 01/22/1991 | US4987122 Peptide compounds and medical method of use thereof |
| 01/22/1991 | US4987121 Erythropoietic factor |
| 01/22/1991 | US4986988 Antitumor agents |
| 01/22/1991 | CA1279278C Fermentation analogs of virginiamycin m1 |
| 01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
| 01/21/1991 | WO1991001328A1 Hirudin peptide derivatives |
| 01/21/1991 | WO1991001142A1 Combinations and methods for treating or preventing thrombotic diseases |
| 01/21/1991 | CA2064231A1 Combinations and methods for treating or preventing thrombotic diseases |
| 01/21/1991 | CA2064195A1 Hirudin peptide derivatives |
| 01/20/1991 | CA2020729A1 Bone morphogenetic protein |
| 01/19/1991 | CA2021369A1 Tumor necrosis factor (tnf) inhibitor and method for obtaining the same |
| 01/18/1991 | WO1991001331A1 Small cyclic platelet aggregation inhibitors |
| 01/18/1991 | CA2063557A1 Small cyclic platelet aggregation inhibitors |
| 01/18/1991 | CA2021166A1 Cheese production |
| 01/17/1991 | DE4022010A1 Anticoagulant compsn. for treatment and prophylaxis of thrombosis - contains vascular anti-coagulant protein (annexine) and divalent salt of calcium, cadmium, zinc, manganese or cobalt |
| 01/17/1991 | DE4020211A1 New rhinoviral DNA with mutation(s) in protease 2A region - and corresponding oligo:nucleotide(s) and oligopeptide(s), useful in test systems and as therapeutic competitive inhibitors |
| 01/17/1991 | DE3943519A1 Treatment of erectile dysfunction - with peptide aspartic-acid -leucine -glutamine -alanine |
| 01/17/1991 | DE3922453A1 Prod. extracted from milk protein hydrolysate - for topical treatment of herpes simplex virus infections |
| 01/16/1991 | EP0408461A1 Protein with urate oxidase activity, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
| 01/16/1991 | EP0408444A2 Galactan extracted Klebsiella, process for its preparation and its use as a medicament |
| 01/16/1991 | EP0408372A1 Anti-viral therapy |
| 01/16/1991 | EP0408371A1 Hemoregulatory peptides |
| 01/16/1991 | EP0408294A2 Use of an amylin antagonist for the manufacture of amedicament for the treatment of obesity and essential hypertension and related disorders |
| 01/16/1991 | EP0408284A2 Amylin for treatment of bone disorders |
| 01/16/1991 | EP0408157A1 Acid-cleavable compound |
| 01/16/1991 | EP0408068A2 Use of ACE-inhibitors for prophylaxis and therapy of chronic veinous insufficiency |
| 01/16/1991 | EP0408044A2 Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives |
| 01/16/1991 | EP0408029A1 Method of fractionating plasma protein |
| 01/16/1991 | EP0407780A2 Ranolazine and related piperazines used in the treatment of tissues experiencing a physical or chemical insult |
| 01/16/1991 | EP0407586A1 Human monoclonal antibody and process for its preparation |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407451A1 General cancer-associated scm-recognition factor, preparation and method of use |
| 01/16/1991 | EP0407430A1 Therapeutic murine monoclonal antibody |
| 01/16/1991 | EP0366777A4 Stimulation of chemotaxis by chemotactic peptides |
| 01/16/1991 | CA2021146A1 Composition comprising an anticoagulant |
| 01/15/1991 | WO1991001333A1 Methods of treating or preventing autoimmune uveoretinitis in mammals |
| 01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | US4985543 Lectins and antiretroviral drugs containing the lectins as active ingredient |
| 01/15/1991 | US4985417 Treatment of glaucoma |
| 01/15/1991 | US4985407 Renin Inhibitors, Treating Cardiovascular Disorders, Hypotensive Agents |